• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number UNKNOWN
Device Problem Material Rupture (1546)
Patient Problems Calcium Deposits/Calcification (1758); Death (1802); Endocarditis (1834); Pseudoaneurysm (2605)
Event Type  Death  
Event Description
Medtronic received information that a retrospective study was performed to evaluate reoperations on patients previously implanted with stentless aortic bioprosthetic valves at one center between 1993 and 2005.The study population included 57 patients (predominantly male; mean age of 63.1 years), ten of which were previously implanted with medtronic valves.Across all patients, a total of six perioperative deaths occurred.Four of the six deaths were associated with medtronic products.Patient 1 presented with endocarditis and a large perivalvular abscess three months post-implant of medtronic bioprosthetic valve.The reoperation included homograft aortic root replacement, tricuspid valve repair and resection, and saphenous vein reconstruction of the left main as well as the proximal left anterior descending, circumflex, and right coronary arteries.The patient was taken to the intensive care unit in stable condition, but then had a sudden cardiac arrest and could not be resuscitated despite emergency bypass of the distal left anterior descending and obtuse marginal arteries.Patient 2 presented with endocarditis with a large abscess and false aneurysm four months post-implant of medtronic bioprosthetic valve.The patient had extreme pericardial adhesions and refractory ventricular fibrillation developed during exposure of the heart.Emergency cardiopulmonary bypass (cpb) through the femoral vessels was followed by homograft aortic root replacement with resection and reconstruction of the intervalvular body, saphenous vein reconstruction of the proximal right coronary artery, and pericardial patch repair of the right pulmonary artery.The patient could not be weaned from cpb and died intraoperatively.Patient 3 had structural valve dysfunction nine post-implant of medtronic bioprosthetic valve.The entire valve was completely calcified and adherent to the aortic root, which necessitated complete root resection and anastomosis of a dacron graft to the left ventricular outflow tract.A mechanical valve was implanted in the dacron graft 6 mm above the proximal suture line, the coronary buttons were re-anastomosed after interposition grafting of the proximal right coronary artery, and a single bypass graft was performed to the distal posterior descending artery.The patient initially did very well, but died four days postoperatively from massive pulmonary embolism.Patient 5 had aortic insufficiency secondary to a torn leaflet seven years post-implant of medtronic bioprosthetic valve.The leaflets of the freestyle valve were removed, and an autologous pericardial patch was used to enlarge the non-coronary sinus and annulus.A size 21 stented bioprosthesis was inserted uneventfully, however after arriving in the intensive care unit the patient had a sudden cardiac arrest and could not be.Autopsy revealed fresh antemortem thrombus on the stented bioprosthesis with emboli down both coronary systems.The cause for the thrombus was never determined.No additional adverse patient effects associated with medtronic products were reported.
 
Manufacturer Narrative
Dates of deaths unknown.The devices were not returned to medtronic.(b)(4).Title: stentless aortic valve reoperations: a surgical challenge authors: michael a.Borger, md, phd, kriengchai prasongsukarn, md, susan armstrong, ms, christopher m.Feindel, md, and tirone e.David, md journal: annal of thoracic surgery 2007;84:737¿ 44).
 
Manufacturer Narrative
Requests for additional information provided no further details.Conclusion: no devices were returned, and no unique device identifier numbers were provided.Without this information a review of the device history record could not be performed and root cause could not be identified.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE AORTIC ROOT BIOPROSTHESIS
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4772490
MDR Text Key5781464
Report Number2025587-2015-00548
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P970031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,foreign,health profe
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/29/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/29/2015
Initial Date FDA Received05/14/2015
Supplement Dates Manufacturer ReceivedNot provided
05/29/2015
Supplement Dates FDA Received06/22/2015
09/18/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age00063 YR
-
-